Pyxis Oncology Inc (PYXS)

$4.40 0.05 (1.12%)

16:00 EDT PYXS Stock Quote Delayed 30 Minutes

3 Biotech Stocks to Buy on the Dip: March 2024

By Ian Cooper, InvestorPlace Contributor Mar 27, 2024

Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.

PYXS Stock Earnings: Pyxis Oncology Beats EPS for Q4 2023

From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

More Articles

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 643,087

Day's Range $4.24 - $4.70

52-Week Range $1.35 - $6.85

Dividend & Yield N/A (N/A)

PYXS Stock Predictions, Articles, and Pyxis Oncology Inc News

From InvestorPlace
From the Web

3 Biotech Stocks to Turn $10,000 Into $1 Million: February 2024

By Ian Cooper, InvestorPlace Contributor Feb 22, 2024

With new innovation and high demand, biotech stocks could offer some of the most explosive opportunities of the year.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Mar 24, 2023

It's time to start off the day with a breakdown of the biggest pre-market stock movers traders need to know about for Friday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Mar 22, 2023

The biggest pre-market stock movers are making waves on Wednesday with huge gainers and losers worth watching this morning!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

By William White, InvestorPlace Writer Dec 5, 2022

The biggest pre-market stock movers for Monday include many Chinese shares that traders will want to keep an eye on today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

By William White, InvestorPlace Writer Dec 1, 2022

Good morning! We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders need to know about!

Pyxis Oncology CEO sells shares worth $18.2k - filing (NASDAQ:PYXS)

From Seeking Alpha Sep 19, 2023

Pyxis Oncology (PYXS) CEO and president Lara Sullivan disclosed in an SEC filing on Monday after the bell a sale of 8,641 shares of the company at prices ranging from $2.1 and $2.25...

Apexigen stock rises on all-stock acquisition by Pyxis Oncology

From Seeking Alpha May 24, 2023

Pfizer (PFE) backed Pyxis Oncology (PYXS) is acquiring Apexigen (APGN) in an all stock deal, for a total enterprise value of ~$16M. Read more here

Pfizer-backed Pyxis Oncology stock hits 52-week high (NASDAQ:PYXS)

From Seeking Alpha Mar 30, 2023

Pyxis Oncology (PYXS) shares reached a new 52-week high as the clinical-stage biotech backed by Pfizer (PFE) crossed $200M market cap on Thursday. Read more here.

PYXS stock surges to hit 11-month high (NASDAQ: PYXS)

From Seeking Alpha Mar 28, 2023

Pyxis Oncology (PYXS), a micro-cap biotech backed by Pfizer (PFE), added ~42% on Tuesday to reach the highest level since April 2022 on rising volume. Read more here.

PYXS stock gains as Pfizer raises stake (NASDAQ:PYXS)

From Seeking Alpha Mar 22, 2023

Pyxis Oncology (PYXS) extended post-market gains Wednesday, adding ~4% in early trading as Pfizer (PFE) raised its ownership in the biotech by more than a third. Read the full story ehre.

Analysts Are Bullish on These Healthcare Stocks: Viridian Therapeutics (VRDN), Pear Therapeutics (PEAR)

From TipRanks Aug 19, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Viridian Therapeutics (

ADVERTISEMENT